Safety and Efficacy Study of Different DAV132 Dose Regimens in Healthy Volunteers
Status:
Completed
Trial end date:
2016-12-02
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate whether different DAV132 dose regimens are safe and
effective for capturing fecal residues of moxifloxacin in healthy volunteers.
Phase:
Phase 1
Details
Lead Sponsor:
Da Volterra
Treatments:
Fluoroquinolones Moxifloxacin Norgestimate, ethinyl estradiol drug combination